An interventional study of Retrograde intrarenal surgery in Renal Calculi, sponsored by Helwan University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-02-03.
Sponsored by Helwan University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Kidney Calculi with a site in Egypt — 21 open to participants now, 23 under way, none of them phase 3. Kidney Calculi · Egypt.
Among the 57 studies in Kidney Calculi with a site in Egypt, this one is the 26th largest by planned enrollment of the 52 interventional ones that give a count, is one of 13 that started in 2026, is one of 49 with no phase, reaches primary completion later than 12 of the 22 other live ones, and was the 45th registered.
510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.
Browse Kidney Calculi studies →21 of the 57 studies in Kidney Calculi with a site in Egypt are open now. Recruiting first, the newest first:
Fayoum University Hospital · Sites in Egypt
Ages 6 mo–15 yrs
Beni-Suef University · Sites in Egypt
Ages 18+
Al-Azhar University · Sites in Egypt
Ages 18–70
Ain Shams University · Sites in Egypt
Ages 18–60
Ain Shams University · Sites in Egypt
Ages 18–71
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 86 across 392 interventional studies indexed under Kidney Calculi.
Median enrollment 100 across the 52 interventional studies, 100 across the 5 observational. Of the 24 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 57 have an industry lead sponsor. The 10 most frequent:
Helwan University is the lead sponsor of 70 studies on the registry; 15 are open to participants now.
Helwan University has 1 study filed under Kidney Calculi — fewer than ten, so there is no comparison to draw.
6 of the studies in Kidney Calculi with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07295860Mansoura UniversityFANS-FURS vs Suction Mini-PCNL for 2-3 cm Renal Stones: A Multicenter Randomized Trial | 2027-01-01 |
| NCT07749807Benha UniversityNebulized Glubran 2-Assisted Tubeless PCNL Versus Conventional PCNL | 2027-02-01 |
| NCT07516535Ain Shams UniversityDISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones | 2027-04-30 |
| NCT07939438Misr University for Science and TechnologyPostoperative Stenting After Flexible Ureteroscopy in Children With Upper Urinary Tract Stones | 2027-05-30 |
| NCT07689565Tanta UniversityStandard Versus Flexible and Navigable Suction Ureteral Access Sheath in Pediatric Flexible Ureterorenoscopy for Renal Stones < 2 cm | 2027-06-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 57 studies in Kidney Calculi with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective, randomized study is comparing the safety and efficacy of using two types of ureteral access sheaths in managing staghorn renal stones by retrograde intrarenal surgery.
Staghorn renal calculi is a complex type of renal calculi characterized by their filling of the renal pelvis and branching into all or part of the renal calyces.
Percutaneous nephrolithotomy (PCNL) is currently the recommended primary treatment option for staghorn renal calculi. However, the procedure has significant drawbacks, including invasiveness, postoperative bleeding, infection, prolonged hospitalization, and slow recovery. Retrograde Intrarenal Surgery (RIRS), an effective minimally invasive procedure, has become the first-line treatment for stones smaller than 2cm. With advancements in endoscopic equipment and techniques, RIRS is also being gradually utilized for the treatment of staghorn renal calculi in patients who are not suitable for PCNL.
Ureteral access sheath (UAS) is an important tool for the endourologist. Advantages of using a UAS in ureteroscopy include: ena¬bling repeated passage of the ureteroscope while mini¬mizing damage, improving the flow of irrigation fluid and visualization within the ureter, reducing operative times, reducing the costs of procedures and improving the effectiveness of surgery.
Intending to overcome the shortages of RIRS, a patented ureter access sheath with features of suction and bendable-tip is designed. The tip of the innovated ureteral access sheath can reach the target calyx along with the flexible ureteroscope.
The adjustable continuous negative pressure suction ensures sufficient irrigation speed and maintains a clear surgical field of view, while effectively removing fragmented stones and dust, and reducing the thermal energy generated by laser lithotripsy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
During retrograde intrarenal surgery, an ureteral access sheath with bendable tip \& connected to suction system will be used.
Procedure: Retrograde intrarenal surgery
During retrograde intrarenal surgery, a conventional ureteral access sheath will be used.
Procedure: Retrograde intrarenal surgery
Retrograde intrarenal surgery with using laser for management of renal staghorn stones
Safety of the surgical technique
Evaluating and comparing the incidence of operative and postoperative complications
Time frame: During surgery to one month after surgery
The efficacy of the surgery
Stone-free rates of the patients will be evaluated by computed tomography after surgery.
Time frame: One month after surgery
Plan to share: No
Started Jan 2026 (actual). Primary completion is estimated for Oct 2026, 8 months after the start.
Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 8 months is below that.
Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Helwan University